Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study

Author:

Hosio Mayu1,Urpilainen Elina2,Hautakoski Ari3,Marttila Mikko4,Arffman Martti5,Sund Reijo6ORCID,Ahtikoski Anne7,Puistola Ulla2,Karihtala Peeter18,Jukkola Arja910,Läärä Esa3

Affiliation:

1. Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland;

2. Department of Obstetrics and Gynaecology, PEDEGO Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland;

3. Research Unit of Mathematical Sciences, University of Oulu, Oulu, Finland;

4. Orion Corporation, Espoo, Finland;

5. Service System Research Unit, Finnish Institute for Health and Welfare, Helsinki, Finland;

6. Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;

7. Cancer and Translational Medicine Research Unit, Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland;

8. Department of Oncology, University of Helsinki and Helsinki University Comprehensive Cancer Center, Helsinki, Finland;

9. Department of Oncology and Radiotherapy, Cancer Centre Tampere, Tampere University Hospital, Tampere, Finland;

10. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3